📖 Approx. 9 min
When considering M&A or business succession for medical corporations, particularly for “fund-contributing medical corporations,” the return of funds is a crucial point. The timing and tax treatment of fund returns are complex, and proceeding without proper understanding can lead to unexpected troubles and financial problems. This article provides a detailed explanation from a professional perspective, covering the basics of fund returns that medical institution managers and succession managers should know, practical aspects in M&A and business succession, and tax considerations.
Basics of Fund-Contributing Medical Corporations and Fund Returns
Medical corporations are broadly divided into “medical corporations with equity” and “medical corporations without equity” based on their establishment structure. Currently, newly established medical corporations are, in principle, limited to those without equity. Among these medical corporations without equity, “funds” are utilized for fundraising at the time of establishment.
Fund-contributing medical corporations receive contributions of funds from founders or third parties and use these funds for the corporation’s operations. Unlike equity in a stock corporation, funds do not grant property rights to members. In other words, those who contribute funds (fund contributors) do not have the right to receive distributions of residual assets corresponding to their contribution amount upon dissolution or withdrawal from the corporation, and the right to claim the return of funds is limited to cases stipulated in the articles of incorporation.
The return of funds is generally made only when stipulated in the articles of incorporation of the medical corporation and to the extent that the corporation’s financial situation permits. Funds form part of the corporation’s net assets, but due to their nature, they differ from ordinary liabilities; the obligation to return them strongly depends on the articles of incorporation and the corporation’s operational status. This is one of the reasons why the handling of funds becomes complicated during M&A and business succession.
Unlike “equity” in medical corporations with equity, funds do not grant property rights (such as the right to claim distribution of residual assets) to contributors. Returns strongly depend on the provisions of the articles of incorporation and the corporation’s financial status.
Timing and Conditions for Fund Returns
The return of funds is not something that can be done freely at any time. It is premised on the articles of incorporation having provisions regarding returns, and several specific conditions must be met for a return to be permitted.
- Provisions in the Articles of Incorporation: The most basic condition is that the articles of incorporation clearly state provisions regarding the return of funds. Specifically, the timing of return, the method of calculating the return amount, and the approval procedures for return must be stipulated.
- Resolution of the General Meeting of Members: Since the return of funds is a significant financial transaction for the corporation, a resolution of the general meeting of members is generally required. This resolution not only approves the execution of the return but also includes a judgment on whether the return is appropriate based on the corporation’s financial situation.
- Existence of Surplus Funds: The return of funds is generally made using the corporation’s surplus funds (such as retained earnings). Returns that would worsen the corporation’s financial condition are not permitted. It is required that the net assets section of the balance sheet remains in a sound state even after the fund return.
- Debt Situation: If the corporation’s ability to pay is significantly reduced by returning funds, the return may not be permitted. Medical institutions often have liabilities such as bank loans, so the relationship with financial institutions and future capital investment plans must also be taken into account.
- Impact on Business Continuity: It is essential to avoid situations where the return of funds leads to a shortage of working capital or capital investment funds necessary for business continuity. It is important to determine whether to return funds after considering future changes in the business environment, such as responses to medical fee revisions and regional medical care plans.
In the context of M&A and business succession, the timing and method of fund returns can significantly influence negotiations on the transfer price and contract terms to ensure post-succession management stability. While the selling side may wish to return funds before succession, the buying side often prefers to keep the funds within the corporation without returning them to stabilize the post-succession financial base.
Tax Treatment of Fund Returns for Medical Corporations
What are the tax implications of fund returns for medical corporations? Here, we explain from the perspective of the medical corporation (corporate tax, consumption tax, business tax).
Corporate Tax Treatment
The return of funds is an act of paying money to a contributor by the corporation, but it is not deductible as an expense (“sonkin”) under the Corporate Tax Law. This is because funds form part of the corporation’s net assets, and their return is considered akin to a capital transaction. Therefore, returning funds does not reduce the corporation’s taxable income or have the effect of reducing the corporate tax amount.
Consumption Tax Treatment
The return of funds does not fall under the category of “transfer of assets, etc.” subject to consumption tax. This is because it is not an economic activity performed in exchange for consideration. Therefore, medical corporations are not required to pay consumption tax when returning funds.
Business Tax Treatment
Business tax, paid to prefectures, is levied on the income generated from the business activities of medical corporations. Since the return of funds does not affect the calculation of the corporation’s income, it has no direct impact on taxable business income. However, there is a possibility that the return of funds may alter the corporation’s financial structure and affect future profit plans.
Tax Treatment of Fund Returns for Contributors
The tax treatment when a fund contributor (individual or corporation) receives a return of funds requires careful judgment depending on the contributor’s status and the nature of the fund.
For Individual Fund Contributors
When funds contributed by an individual are returned, they generally do not fall under “capital gains.” This is because funds do not carry property rights, unlike the transfer of securities such as stocks. If the returned fund amount is the same as the contributed amount, no income tax will be levied. This is because it is considered merely the return of contributed money.
However, if, for example, an amount exceeding the contributed amount is paid upon the return of funds, the difference may be taxed as “special income” or “miscellaneous income.” Specifically, this applies when the fund return is considered to have been effectively made as consideration for the medical corporation’s business activities, or when it is determined to be an unreasonably high return. This judgment largely depends on the individual assessment of the tax office, so it is essential to consult with a tax professional such as a certified public accountant in advance.
For Corporate Fund Contributors
When a corporation contributes funds and receives their return, no tax issues arise in principle within the scope of the contributed amount. However, similar to individuals, if an amount exceeding the contributed amount is returned, the difference may be included in the corporation’s gross income as equivalent to “dividends received” or “interest received” and become subject to corporate tax.
In either case, the tax treatment must be determined by comprehensively considering the circumstances at the time of fund contribution, the background of the return, and the provisions of the articles of incorporation. Especially when fund returns occur during M&A or business succession, complex tax risks arise, such as whether it could be considered part of the transfer price, making professional due diligence extremely important.
Practical Aspects and Precautions for Fund Returns in M&A and Business Succession
In M&A and business succession of medical corporations, fund returns are one of the important check items in due diligence. Especially for the acquiring party, careful consideration is required as it directly relates to post-succession financial stability and business plans.
Due Diligence Checkpoints
- Review of Articles of Incorporation: Confirm whether provisions regarding fund returns are clearly stipulated and whether the conditions are realistic.
- Analysis of Financial Statements: Evaluate the amount of funds, the status of surplus funds, and the debt situation to assess the amount that can be returned and the corporation’s ability to pay. If there are past return records, review their background.
- Relationship with Fund Contributors: If the fund contributors are the current chairman or their relatives, prior agreement is necessary to prevent potential demands for returns after the M&A.
- Impact on Business Plan: Consider whether the fund return will hinder post-succession capital investment plans or securing working capital.
Impact on Sale Price and Negotiations
The return of funds effectively reduces the net assets of the medical corporation, which can affect the sale price in M&A. For example, if the selling party wishes to return funds before succession, it results in the outflow of corporate assets, potentially creating room for negotiation to lower the sale price. Conversely, if the acquiring party wishes to retain the funds within the corporation without returning them to strengthen the post-succession financial base, this may be reflected in the sale price.
Furthermore, if the fund contributors are the current chairman or related parties, it is common to include specific agreement clauses in the M&A contract regarding the timing, amount, and method of fund returns. This helps prevent future troubles and ensures a transparent transaction for both parties.
Relation to Regional Medical Care Plans and Licenses
Weakening the financial base of a corporation due to fund returns can also affect its ability to respond to regional medical care plans and maintain various licenses. For example, situations where new facility standards cannot be met or necessary capital investments cannot be made due to lack of funds must be avoided. To maintain a stable medical service provision system after business succession, fund return plans must be carefully established.
Comparison of Medical Corporations Without Equity and Fund-Contributing Medical Corporations
Here, we compare the main differences between fund-contributing medical corporations and other medical corporations without equity (mainly those not utilizing fund systems).
| Item | Fund-Contributing Medical Corporation | Medical Corporation Without Equity (No Fund System) |
|---|---|---|
| Trend in Establishment Period | Many established after April 2007 | Many established after April 2007 |
| Fundraising Method | Fund contributions | Donations, loans, etc. |
| Return to Contributors | Return possible based on provisions in articles of incorporation and conditions | No return in principle (as it is a donation) |
| Presence of Property Rights | No property rights for contributors | No property rights for contributors |
| Issues in M&A | Timing of fund return, tax treatment, impact on sale price | Fundraising methods and debt situation are main issues |
| Tax Considerations | Income classification for contributors upon return, non-deductibility for corporation | Application of donation tax credit, etc. |
As can be seen from this comparison table, there are unique issues related to fund returns in M&A and business succession for fund-contributing medical corporations. Deeply understanding these differences and formulating appropriate strategies is key to success when considering succession.
Conclusion: Fund Returns are a Critical Specialized Area in M&A and Succession
The return of funds for medical corporations is not merely a transfer of money but a complex process deeply intertwined with the corporation’s financial status, its articles of incorporation, and the tax implications for related parties. Especially in the context of M&A and business succession, its handling significantly impacts the success and terms of the transaction, making specialized knowledge and experience indispensable.
Mistakes in the timing of fund returns or incorrect tax treatment carry the risk of unexpected troubles and additional tax burdens. Medical institution managers, or those considering succession, must obtain accurate information regarding fund returns and proceed with caution, in collaboration with M&A and succession specialists. M&A Medical offers optimal solutions based on extensive experience and specialized knowledge for complex cases, including the return of funds for medical corporations. We also offer free consultations, so please feel free to contact us.
Consultations on Medical Succession with M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the transfer of clinics and medical corporations facing successor shortages, as well as strategic acquisitions, on a success-fee basis.
- Initial consultation and preliminary appraisal are free
- No upfront fees or monthly charges (success fee only)
- Strict confidentiality (proceeds after signing an NDA)
- Support available nationwide in all 47 prefectures and for all medical specialties
Please consult with us early, even in the initial stages of consideration, whether you just want to know the market value, have no successor, or are considering joining a group.